Galaxy Diagnostics
Durham
About Galaxy Diagnostics
Galaxy Diagnostics is an early-stage infectious disease diagnostic company, specializing in the detection of Bartonella. Bartonella is bacteria that cause zoonotic infections – i.e., Bartonella may be transmitted from an animal host (usually a cat) to people. Vectors, like fleas, lice, ticks, and biting flies also play an important role in transmission. People who work and live with animals are at higher risk of infection. Bartonella are a key agents in Cat Scratch Disease and a few other known diseases. Bartonella was recently (re)discovered in HIV patients in the 1990s and found to cause of many life-threatening complications in HIV patients, including skin rashes and heart and liver infections. Galaxy Diagnostics was founded in 2009 and is based in Durham, North Carolina, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.7M
- Funding stage: Early Stage Venture
- Last round: Series Unknown (Apr 2025)
- Website: galaxydx.com
- Phone: 9192872476
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/galaxy-diagnostics-128556 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.